Fujita Medical Journal (Aug 2023)

Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease

  • Chika Fujisawa-Tanaka,
  • Izumi Hiratsuka,
  • Megumi Shibata,
  • Kei Kurihara,
  • Naohiro Aida,
  • Takeshi Takayanagi,
  • Yusuke Seino,
  • Taihei Ito,
  • Takashi Kenmochi,
  • Atsushi Suzuki

DOI
https://doi.org/10.20407/fmj.2022-019
Journal volume & issue
Vol. 9, no. 3
pp. 194 – 199

Abstract

Read online

Objectives: Type 1 diabetes mellitus (T1DM) patients with diabetic kidney disease-induced kidney failure have a significantly impaired quality of life (QOL), resulting in a high level of physical, mental, and social anxiety. In this study, we evaluated the QOL of T1DM patients on the list for pancreas transplantation (PTx) at their registration, and determined whether PTx improved their QOL. Methods: There were 58 patients (men/women, 22/36; mean age, 42.8±8.0 years) with T1DM and who were registered on the waiting list for PTx. Quantitative QOL assessment was performed using the Medical Health Survey Short Form (SF-36) version 2. Changes in the QOL before and after PTx were also examined in 24 of these patients. Results: The mean value of each endpoint and the summary score of the SF-36 physical (PCS), mental (MCS), and role (RCS) components were all below the national normal level at PTx registration. No significant difference in QOL scores was observed in the intergroup comparison of 35 patients on dialysis, 13 patients without dialysis, and ten patients after kidney transplantation. The 24 patients who underwent PTx showed improvement in PCS, MCS, and most SF-36 scores. Conclusion: T1DM patients waiting for PTx had a decreased QOL, regardless of dialysis, and PTx improved their QOL.

Keywords